Pub Date : 2026-01-10DOI: 10.1016/j.jvir.2025.107960
Hiroyuki Tokue MD, Yoshito Tsushima MD
{"title":"Letter to “Safety and Effectiveness of Transarterial Chemoembolization for Caudate Lobe Hepatocellular Carcinoma: Long-Term Clinical Outcomes”","authors":"Hiroyuki Tokue MD, Yoshito Tsushima MD","doi":"10.1016/j.jvir.2025.107960","DOIUrl":"10.1016/j.jvir.2025.107960","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 4","pages":"Article 107960"},"PeriodicalIF":2.6,"publicationDate":"2026-01-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145960608","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-09DOI: 10.1016/j.jvir.2026.107990
Osman Ahmed MD , Faisal F. Al-Qawasmi MD , Magdalena Anitescu MD, PhD , Sara Wallace MD , Tessa Balach MD , Brendon Ross DO , Gregory Scott Stacy MD , Timothy Carroll PhD , Theodore Karrison PhD , Hollis Potter MD , Akhilesh Sista MD , Joel A. Block MD
{"title":"SHAM-PAIN Trial: Genicular Artery Embolization for Reducing Pain in Medically Refractory Symptomatic Knee Osteoarthritis—A Randomized Sham-Controlled Pilot Study","authors":"Osman Ahmed MD , Faisal F. Al-Qawasmi MD , Magdalena Anitescu MD, PhD , Sara Wallace MD , Tessa Balach MD , Brendon Ross DO , Gregory Scott Stacy MD , Timothy Carroll PhD , Theodore Karrison PhD , Hollis Potter MD , Akhilesh Sista MD , Joel A. Block MD","doi":"10.1016/j.jvir.2026.107990","DOIUrl":"10.1016/j.jvir.2026.107990","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 4","pages":"Article 107990"},"PeriodicalIF":2.6,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145953557","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-09DOI: 10.1016/j.jvir.2026.107993
Steven Kum MD , Sven Bräunlich MD , Ehrin J. Armstrong MD , Koen Deloose MD , Mark J. Portou MD , Marianne Brodmann MD , Edwaldo Edner Joviliano MD, PhD , Gabriel Fernando Mejia-Villate MD , Jinoo Kim MD, PhD , Chung-Ho Hsu MD , Thatchawit Urasuk MD , Prem Chand Gupta MD , Varinder Singh Bedi MS , Tim Shiraev MD, MBBS , Shannon Thomas (FRACS, PhD) , Osamu Iida MD , Masahiko Fujihara MD , Zhenyu Shi MD, PhD , Dheeraj K. Rajan MD , Fabrizio Fanelli MD
Purpose
To provide recommendations for the most appropriate endovascular intervention of femoropopliteal (FP) arterial disease based on plaque characterization.
Materials and Methods
A panel of 22 physicians from multiple disciplines participated in a modified Delphi consensus, leveraging the RAND/UCLA Appropriateness Method. Panelists engaged in 2 rounds of voting, following a literature review, with an in-person discussion prior to the second round of voting. A rigorous statistical approach was used to analyze the points of agreement and disagreement. Consensus-based recommendations on the most appropriate endovascular approaches for treating patients with FP lesions, stratified by lesion morphology, were generated.
Results
Overall, 490 individual items were included in the voting, 458 (93%) of which achieved consensus and 32 (7%) were nonconsensus items, based on a priori criteria under the following categories: (a) recommendations on method for determining plaque morphology, (b) preferred endovascular devices for vessel preparation and definitive treatment stratified by (i) plaque morphology and (ii) Tosaka classification of in-stent restenosis, and (c) vessel preparation device safety-related considerations.
Conclusions
This international, multidisciplinary consensus provides evidence- and expert-informed recommendations for vessel preparation and definitive treatment of FP arterial disease, tailored to plaque morphology. These consensus recommendations aim to support clinical decision making and promote best interventional practices by serving as an expert opinion supplement to existing guideline-based care pathways.
{"title":"Consensus-Driven Vessel Preparation and Definitive Endovascular Treatment Strategies for Femoropopliteal Arterial Lesions Based on Plaque Morphology","authors":"Steven Kum MD , Sven Bräunlich MD , Ehrin J. Armstrong MD , Koen Deloose MD , Mark J. Portou MD , Marianne Brodmann MD , Edwaldo Edner Joviliano MD, PhD , Gabriel Fernando Mejia-Villate MD , Jinoo Kim MD, PhD , Chung-Ho Hsu MD , Thatchawit Urasuk MD , Prem Chand Gupta MD , Varinder Singh Bedi MS , Tim Shiraev MD, MBBS , Shannon Thomas (FRACS, PhD) , Osamu Iida MD , Masahiko Fujihara MD , Zhenyu Shi MD, PhD , Dheeraj K. Rajan MD , Fabrizio Fanelli MD","doi":"10.1016/j.jvir.2026.107993","DOIUrl":"10.1016/j.jvir.2026.107993","url":null,"abstract":"<div><h3>Purpose</h3><div>To provide recommendations for the most appropriate endovascular intervention of femoropopliteal (FP) arterial disease based on plaque characterization.</div></div><div><h3>Materials and Methods</h3><div>A panel of 22 physicians from multiple disciplines participated in a modified Delphi consensus, leveraging the RAND/UCLA Appropriateness Method. Panelists engaged in 2 rounds of voting, following a literature review, with an in-person discussion prior to the second round of voting. A rigorous statistical approach was used to analyze the points of agreement and disagreement. Consensus-based recommendations on the most appropriate endovascular approaches for treating patients with FP lesions, stratified by lesion morphology, were generated.</div></div><div><h3>Results</h3><div>Overall, 490 individual items were included in the voting, 458 (93%) of which achieved consensus and 32 (7%) were nonconsensus items, based on a priori criteria under the following categories: (<em>a</em>) recommendations on method for determining plaque morphology, (<em>b</em>) preferred endovascular devices for vessel preparation and definitive treatment stratified by (<em>i</em>) plaque morphology and (<em>ii</em>) Tosaka classification of in-stent restenosis, and (<em>c</em>) vessel preparation device safety-related considerations.</div></div><div><h3>Conclusions</h3><div>This international, multidisciplinary consensus provides evidence- and expert-informed recommendations for vessel preparation and definitive treatment of FP arterial disease, tailored to plaque morphology. These consensus recommendations aim to support clinical decision making and promote best interventional practices by serving as an expert opinion supplement to existing guideline-based care pathways.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 4","pages":"Article 107993"},"PeriodicalIF":2.6,"publicationDate":"2026-01-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145953481","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-05DOI: 10.1016/j.jvir.2025.107956
{"title":"Crossword Puzzle","authors":"","doi":"10.1016/j.jvir.2025.107956","DOIUrl":"10.1016/j.jvir.2025.107956","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 3","pages":"Article 107956"},"PeriodicalIF":2.6,"publicationDate":"2026-01-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145927348","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-03DOI: 10.1016/j.jvir.2025.107989
Erez Klein MD , Marcell Gyano MD, PhD , Vaiva Gustainyte DO , Junsung Choi MD , Bela Kis MD, PhD
Purpose
To assess the safety of adrenal biopsies in patients with known or suspected malignancies without preprocedural endocrine evaluations.
Materials and Methods
This was a single-center retrospective study that included 426 patients (249 men and 177 women; mean age, 66.1 years [SD ± 11.0]) with known or suspected malignancy who underwent 487 computed tomography (CT)–guided adrenal biopsies between October 2011 and December 2023. The authors analyzed medical records and cross-sectional imaging, evaluating technical and diagnostic success rates as well as complications.
Results
Of the 487 biopsies, 442 (91%) were performed in patients with confirmed malignancies, whereas 45 cases (9%) were patients presenting with new abdominal or lung mass and adrenal mass. The most common primary malignancy was lung cancer (272 of 487, 56%). Technical success rate was 99.8% (486 of 487), with a diagnostic success rate of 97.1% (473 of 487). Histopathological findings differed from known primary malignancy in 2.9% (14 of 487) of cases. Endocrine assessments were performed before 40 biopsies (8.2%). Three (3 of 487, 0.61%) new histological diagnoses of pheochromocytoma emerged, with 2 (66%) occurring in patients with known malignancies. A total of 45 adverse events (9.2%) were observed, primarily Grades 1–2, with only 6 classified as Grade 3 (4 hemorrhages and 2 cases of hypertension). Only 1 case of Grade 3 hypertension linked to pheochromocytoma.
Conclusions
Incidence of pheochromocytoma in patients with known or suspected extra-adrenal malignancies without endocrine workup was less than 1%. Therefore, endocrine workup prior to adrenal biopsies in patients with known and suspected malignancies may not be indicated despite recommendations of international guidelines.
{"title":"Percutaneous Adrenal Biopsies in Patients with Cancer: The Utility of Preprocedural Endocrine Workup","authors":"Erez Klein MD , Marcell Gyano MD, PhD , Vaiva Gustainyte DO , Junsung Choi MD , Bela Kis MD, PhD","doi":"10.1016/j.jvir.2025.107989","DOIUrl":"10.1016/j.jvir.2025.107989","url":null,"abstract":"<div><h3>Purpose</h3><div>To assess the safety of adrenal biopsies in patients with known or suspected malignancies without preprocedural endocrine evaluations.</div></div><div><h3>Materials and Methods</h3><div>This was a single-center retrospective study that included 426 patients (249 men and 177 women; mean age, 66.1 years [SD ± 11.0]) with known or suspected malignancy who underwent 487 computed tomography (CT)–guided adrenal biopsies between October 2011 and December 2023. The authors analyzed medical records and cross-sectional imaging, evaluating technical and diagnostic success rates as well as complications.</div></div><div><h3>Results</h3><div>Of the 487 biopsies, 442 (91%) were performed in patients with confirmed malignancies, whereas 45 cases (9%) were patients presenting with new abdominal or lung mass and adrenal mass. The most common primary malignancy was lung cancer (272 of 487, 56%). Technical success rate was 99.8% (486 of 487), with a diagnostic success rate of 97.1% (473 of 487). Histopathological findings differed from known primary malignancy in 2.9% (14 of 487) of cases. Endocrine assessments were performed before 40 biopsies (8.2%). Three (3 of 487, 0.61%) new histological diagnoses of pheochromocytoma emerged, with 2 (66%) occurring in patients with known malignancies. A total of 45 adverse events (9.2%) were observed, primarily Grades 1–2, with only 6 classified as Grade 3 (4 hemorrhages and 2 cases of hypertension). Only 1 case of Grade 3 hypertension linked to pheochromocytoma.</div></div><div><h3>Conclusions</h3><div>Incidence of pheochromocytoma in patients with known or suspected extra-adrenal malignancies without endocrine workup was less than 1%. Therefore, endocrine workup prior to adrenal biopsies in patients with known and suspected malignancies may not be indicated despite recommendations of international guidelines.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 4","pages":"Article 107989"},"PeriodicalIF":2.6,"publicationDate":"2026-01-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145906698","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.jvir.2025.107914
{"title":"Crossword Puzzle","authors":"","doi":"10.1016/j.jvir.2025.107914","DOIUrl":"10.1016/j.jvir.2025.107914","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 1","pages":"Article 107914"},"PeriodicalIF":2.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145883421","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.jvir.2025.10.004
Arman Sarshoghi , Arash Sarshoghi MSc , Maxime Têtu MSc , Calvin S.H. Ng MD , Lonny Yarmus DO , Patrick Bourgouin MD , Stephen B. Solomon MD , Felix Herth MD, PhD , Robert P. Liddell MD , Moishe Liberman MD, PhD
Purpose
To evaluate 1-year local tumor control (LTC) after percutaneous cryoablation for lung tumors and to identify procedural protocol and patient/tumor characteristics associated with improved outcomes.
Materials and Methods
A systematic search of PubMed, Embase, and Web of Science was conducted. The primary outcome was LTC at 1 year. Secondary outcomes included the identification of factors associated with LTC and pooled adverse event rates, such as freezing lengths, number of cycles, tumor characteristics, and more. Data were pooled using a random-effects model, and meta-regression was used to analyze factors affecting LTC.
Results
Nineteen studies (786 patients, 1,048 tumors) yielded a pooled 1-year LTC of 90.5% (95% CI, 85.1%–94.1%). Multivariate meta-regression showed that smaller tumor size was significantly associated with improved LTC. Univariate analysis also identified that superior LTC was associated with a triple freeze-thaw protocols (vs double), a shorter first freeze duration, a longer final freeze duration, and ending the procedure with a thaw cycle. The incidence of adverse events (Common Terminology Criteria for Adverse Events [CTCAE] Grade ≥3) was 4.9% (95% CI, 2.9%–6.9%), with pneumothorax most common (28% of cases).
Conclusions
Percutaneous cryoablation demonstrates high effectiveness for lung tumor control. Superior 1-year LTC is associated with smaller tumor size and a triple freeze-thaw protocol characterized by a short initial freeze followed by longer subsequent freezes. These findings provide a data-driven basis for standardizing cryoablation techniques.
目的：本系统综述和荟萃分析旨在评估经皮肺肿瘤冷冻消融后1年的局部肿瘤控制（LTC），并确定与改善预后相关的手术方案和患者/肿瘤特征。方法：系统检索PubMed、EMBASE和Web of Science。主要终点为1年LTC。次要结局包括确定与LTC和汇总不良事件发生率相关的因素，如冷冻时间、周期数、肿瘤特征等。采用随机效应模型对数据进行汇总，并采用元回归分析影响LTC的因素。结果：19项研究（786例患者，1048个肿瘤）得出的1年总LTC为90.5% （95% CI, 85.1%-94.1%）。多变量荟萃回归显示，较小的肿瘤大小与LTC改善显著相关。单变量分析还发现，较好的LTC与三次冻融方案（与两次冻融方案相比）、较短的首次冻融持续时间、较长的最终冻融持续时间以及以解冻周期结束的过程有关。不良事件（CTCAE分级≥3）发生率为4.9% (95% CI: 2.9%-6.9%)，其中气胸最为常见（28%的病例）。结论：经皮冷冻消融治疗肺肿瘤疗效显著。优越的1年LTC与较小的肿瘤大小和三重冻融方案相关，其特征是初始冻结时间短，随后冻结时间长。这些发现为标准化冷冻消融技术提供了数据驱动的基础。
{"title":"Cryoablation Protocols for Primary and Metastatic Lung Tumors: A Systematic Review and Meta-Analysis Evaluating Effectiveness and Safety of Percutaneous Cryoablation of Pulmonary Tumors","authors":"Arman Sarshoghi , Arash Sarshoghi MSc , Maxime Têtu MSc , Calvin S.H. Ng MD , Lonny Yarmus DO , Patrick Bourgouin MD , Stephen B. Solomon MD , Felix Herth MD, PhD , Robert P. Liddell MD , Moishe Liberman MD, PhD","doi":"10.1016/j.jvir.2025.10.004","DOIUrl":"10.1016/j.jvir.2025.10.004","url":null,"abstract":"<div><h3>Purpose</h3><div>To evaluate 1-year local tumor control (LTC) after percutaneous cryoablation for lung tumors and to identify procedural protocol and patient/tumor characteristics associated with improved outcomes.</div></div><div><h3>Materials and Methods</h3><div>A systematic search of PubMed, Embase, and Web of Science was conducted. The primary outcome was LTC at 1 year. Secondary outcomes included the identification of factors associated with LTC and pooled adverse event rates, such as freezing lengths, number of cycles, tumor characteristics, and more. Data were pooled using a random-effects model, and meta-regression was used to analyze factors affecting LTC.</div></div><div><h3>Results</h3><div>Nineteen studies (786 patients, 1,048 tumors) yielded a pooled 1-year LTC of 90.5% (95% CI, 85.1%–94.1%). Multivariate meta-regression showed that smaller tumor size was significantly associated with improved LTC. Univariate analysis also identified that superior LTC was associated with a triple freeze-thaw protocols (vs double), a shorter first freeze duration, a longer final freeze duration, and ending the procedure with a thaw cycle. The incidence of adverse events (Common Terminology Criteria for Adverse Events [CTCAE] Grade ≥3) was 4.9% (95% CI, 2.9%–6.9%), with pneumothorax most common (28% of cases).</div></div><div><h3>Conclusions</h3><div>Percutaneous cryoablation demonstrates high effectiveness for lung tumor control. Superior 1-year LTC is associated with smaller tumor size and a triple freeze-thaw protocol characterized by a short initial freeze followed by longer subsequent freezes. These findings provide a data-driven basis for standardizing cryoablation techniques.</div></div>","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 1","pages":"Article 107871"},"PeriodicalIF":2.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145276537","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
Pub Date : 2026-01-01DOI: 10.1016/j.jvir.2025.10.008
Peter M. Do BS , James Y. Lim MD , Keith B. Quencer MD , Brian J. Park MD, MS
{"title":"Single-Session Ethanol Sclerotherapy for Symptomatic Simple Adrenal Cysts","authors":"Peter M. Do BS , James Y. Lim MD , Keith B. Quencer MD , Brian J. Park MD, MS","doi":"10.1016/j.jvir.2025.10.008","DOIUrl":"10.1016/j.jvir.2025.10.008","url":null,"abstract":"","PeriodicalId":49962,"journal":{"name":"Journal of Vascular and Interventional Radiology","volume":"37 1","pages":"Article 107876"},"PeriodicalIF":2.6,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"145370528","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
扫码关注我们
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号